Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126131191 | 12613119 | 1 | I | 20160719 | 20160802 | 20160802 | EXP | US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-120712 | RANBAXY | MCKEE B, REY JA. PAROXETINE-BOOSTED RISPERIDONE: A CASE REPORT. J PHARM PRACT. 2013;JUN;26(3):344 | 30.00 | YR | M | Y | 0.00000 | 20160802 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126131191 | 12613119 | 1 | PS | RISPERIDONE. | RISPERIDONE | 1 | Oral | 4 MG, BID | U | 77542 | 4 | MG | Q12H | ||||||
| 126131191 | 12613119 | 2 | SS | RISPERIDONE. | RISPERIDONE | 1 | Intramuscular | 50 MG, 2/WEEK | U | 0 | 50 | MG | BIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126131191 | 12613119 | 1 | Product used for unknown indication |
| 126131191 | 12613119 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126131191 | 12613119 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126131191 | 12613119 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |